You are here

  • Home
  • Archive
  • Volume 30, Issue 4
  • Comparison of medium-term adverse reactions induced by the first and second dose of mRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine: a post-marketing Italian study conducted between 1 January and 28 February 2021

Article metrics

Article menu
Download PDFPDF
Original research
Comparison of medium-term adverse reactions induced by the first and second dose of mRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine: a post-marketing Italian study conducted between 1 January and 28 February 2021

 

Online download statistics by month:

Online download statistics by month: July 2021 to August 2024

AbstractFullPdf
Jul 202131930877
Aug 2021761619223
Sep 2021944825152
Oct 20211014807227
Nov 2021958681193
Dec 2021995758160
Jan 2022733571110
Feb 202243938575
Mar 202282577670
Apr 202237832864
May 202224220849
Jun 202217114840
Jul 202220117929
Aug 202218216837
Sep 202221819625
Oct 202220417629
Nov 202217315319
Dec 202215513222
Jan 202314712823
Feb 202313812217
Mar 202320918617
Apr 2023293288
May 202328104
Jun 202355635
Jul 20231313927
Aug 20231114716
Sep 2023605113
Oct 202363426
Nov 2023800410
Dec 202335725
Jan 202416905
Feb 202412312
Mar 202423704
Apr 202424846
May 202414811
Jun 202412306
Jul 20249114
Aug 202414104
Total1663979171784